Related Experiment Video
Updated: Jun 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
[Prognostic differences among different age limits in Chinese elderly patients with non-Hodgkin's lymphoma]
Hai-Yan Xie1, Dao-Bin Zhou, Shu-Jie Wang
1International Medical Service, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
Objective:
To explore the feasible age limits in Chinese elderly patients with non-Hodgkin's lymphoma (NHL).
Methods:
The clinical data of 507 patients with NHL who were admitted to Peking Union Medical College Hospital (PUMCH) from January 1990 to December 2007 were retrospectively analyzed. They were further followed up by reviewing medical records or by phone. The deadline of follow-up was October 2008.
Results:
The 5-year/8-year overall survival (OS) rates were 64.6%/45.7%, 53.0%/ 44.1%, 32.8%/17.5%, 40.0%/22.8%, and 19.8%/0, respectively, in patients aged < 60 years, 60-64 years, 65-69 years, 70-74 years, and > or = 75 years. The OS rate was significantly different between patients aged > or = 75 years and other age groups, and between patients aged 65-70 years and patients younger than 60 years (P < 0.05). Only age, serum albumin, and hemoglobin affected the survival status in elderly NHL patients.
Conclusion:
Sixty-five years can be regarded as the age limit in Chinese NHL patients.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Comparing the Survival Analysis of Two or More Groups